Life Science Success Don Davis PhD, MBA

In this episode of the Life Science Success Podcast, host Don interviews Sean Rothwell, CEO of Evoke Nano, about the company's groundbreaking work in developing EBQ218, a revolutionary nanoparticle-based pulmonary therapeutic. They discuss the efficacy of EBQ218 in treating cystic fibrosis and its potential as a broad-spectrum antibiotic against drug-resistant superbugs. Sean shares insights into the company's journey, their upcoming clinical trials, and the broader impact of their work on patient outcomes in the healthcare landscape. Tune in to learn how Evoke Bio is poised to make a significant difference in combating infectious diseases and improving lives.
 
 
00:00 Welcome and Introduction
00:09 First Impressions of BIO Conference
00:37 Sean's Background and Journey into Life Sciences
01:42 The Science Behind Evoke Nano
02:28 EBQ218: A Revolutionary Pulmonary Therapeutic
04:16 Challenges and Future Pathways
05:24 Investment and Partnership Opportunities
06:42 Broader Applications and Future Vision
08:16 Addressing Drug Resistance and Regulatory Pathways
18:48 Conclusion and Final Thoughts

This is the second part of the interview where, with Maruiano, we will discuss more of the technology and development for Elem Biotech.  
 
In this episode of the Life Science Success Podcast, Don Davis discusses the BIO conference and the future of biomedical research with Mauriano Vázquez. They delve into the significance of networking events, the evolution of computing capabilities, advanced simulation codes, and the potential applications of AI and quantum computing in life sciences. Mauriano shares his unique journey from Argentina to becoming a physicist specializing in computational mechanics, and how his work in cardiac electrophysiology can significantly impact patient care. The conversation wraps up with insights into the future use of virtual and augmented reality in medical applications.
 
 
00:00 Introduction and Conference Impressions
02:37 Mariano's Background and Journey into Life Sciences
06:22 Applications of Simulation Technology
10:48 Evolution of Computing Capabilities
13:37 Future of AI and Quantum Computing
14:41 Virtual Reality in Medical Applications
19:40 Conclusion and Final Thoughts

There are two parts of this interview, in the first session, I dive into Elem and what the company is doing with Christopher Morton.  
 
In this exciting episode of Life Science Discussed Podcast, host Don Davis welcomes Christopher Morton, CEO of Elem Biotech, to talk about the groundbreaking work of virtual human twins in drug and medical device testing. Morton, an aeronautical engineer turned biotech innovator, discusses Elem's platform that allows pharmaceutical companies, medtechs, and CROs to test new therapeutics using virtual human models instead of animal models. They delve into how this approach, distinct from AI-based methods, focuses on mechanistic modeling using MRIs and CT scans to replicate human physiological functions. Morton explains how Elem Biotech's solutions help in precision medicine, clinical trial design, and reducing animal trials, supported by supercomputing power and cloud technology. Tune in to discover how virtual human models are poised to transform life sciences and medical testing.
 
00:00 Introduction and Welcome
00:43 Christopher Morton's Background
01:57 Introduction to Elem Biotech
02:45 Mechanistic Approach vs. AI Models
03:47 Precision Medicine and Virtual Human Twins
08:58 Supercomputing and Technological Infrastructure
13:07 Applications in Pharma and Medical Devices
21:07 Challenges and Future Directions
25:59 Conclusion and Final Thoughts

In this episode of the Lifescience Success Podcast, host Don Davis interviews James Hackworth, who shares insights about his background in physics and his journey into the life science industry. James discusses his experiences from McKinsey up to his current role at Tris Pharma, focusing on their innovative drug development and formulation technologies. He dives into the company's advancements in ADHD medications and an exciting new pain management drugs. Additionally, the conversation highlights the importance of partnerships, technology in drug development, and future industry trends. James provides a fascinating glimpse into the complexities and future of pharmaceuticals.

00:00 Welcome and Introduction
00:08 Impressions of the Bio Conference
00:42 James' Background and Journey into Pharma
03:17 Formation and Growth of Park Therapeutics
04:20 Overview of Tris Pharma
04:41 Tris Pharma's Focus and Innovations
08:00 Challenges and Opportunities in Partnering
10:58 Future of Tris Pharma and the Industry
15:41 In-depth Look at Drugs that are progressing
19:21 Conclusion and Final Thoughts

In this episode of the Life Science Success Podcast, Don interviews Himanshu Gadgil  from Enzine during Bio International. Himanshu explains Enzine’s dual focus on developing biosimilars and their role as a CDMO with a game-changing platform, Enzine X. They discuss how Enzine's continuous manufacturing technology significantly cuts costs and speeds up market access for clients. Himanshu also talks about Enzine’s global presence, clientele, and their future plans for expansion in the U.S. and India. Tune in to learn about the innovative approaches Enzine is bringing to the biotech industry.
 
00:00 Welcome and Introduction
00:07 Overview of Enzine Biotech
00:26 Enzine's Unique Manufacturing Platform
01:08 Clientele and Market Reach
01:41 Timelines and Efficiency
02:08 Future of Continuous Manufacturing
04:22 Geographical Expansion and Workforce
05:02 Enzine's Differentiators
06:10 Conclusion and Final Thoughts

 

Welcome to the Life Science Success Podcast! In this episode, host Don interviews Catherine from Jellox Biotech at Bio Interntional June of 2024. Catherine shares insights into her journey from financial engineering to the life sciences field, her experience in investment banking, and her current role in business development at Jellox Biotech. She discusses Jellox Biotech's groundbreaking 3D imaging technology for digital pathology, its benefits for early cancer diagnosis, and the company's expansion plans. Catherine also sheds light on the challenges and hopes for the future, especially regarding raising venture capital and global outreach.
 
 
00:00 Introduction and Guest Welcome
00:07 Catherine's Background and Career Journey
00:43 Introduction to Jellox Biotech
01:11 Innovations in 3D Imaging and Digital Pathology
02:22 Product Development and Market Expansion
03:56 Challenges and Goals at Bio Conference
08:06 Global Expansion Plans
09:37 Future Aspirations and Technological Impact
15:39 Conclusion and Farewell